AIC
TEVA icon

Ameritas Investment Company’s Teva Pharmaceuticals TEVA Stock Holding History

Ameritas Investment Company’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-571
Closed -$6.59K – 1943
2021
Q1 		$6.59K Buy
+571
New +$6.55K ﹤0.01% 1645
2020
Q2 		– Sell
-519
Closed -$4K – 1472
2020
Q1 		$4K Buy
+519
New +$5.32K ﹤0.01% 1462
2019
Q4 		– Sell
-189
Closed -$2K – 1455
2019
Q3 		$2K Buy
+189
New +$1.45K ﹤0.01% 1495
2019
Q2 		– Sell
-217
Closed -$3K – 811
2019
Q1 		$3K Buy
+217
New +$3.83K ﹤0.01% 830

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Ameritas Investment Company's TEVA Position: Q2 2021 in Review

Ameritas Investment Company sold out of Teva Pharmaceuticals (TEVA) in Q2 2021, closing a stake of 571 shares — an estimated $6.59K sold.

Ameritas Investment Company first reported a position in TEVA in Q1 2019 and held it in 4 quarters. The position peaked at $6.59K in Q1 2021. 440 funds tracked by Wall St. Rank hold TEVA as of Q2 2021.

  • Ameritas Investment Company reported no remaining Teva Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 571 Teva Pharmaceuticals shares in Q2 2021, an estimated $6.59K.
  • Ameritas Investment Company first reported a position in Teva Pharmaceuticals in Q1 2019 and held it in 4 quarters.
  • Ameritas Investment Company's Teva Pharmaceuticals position peaked at $6.59K in Q1 2021.
  • 440 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.